News

As of 23 January, the samples of 4 (four) athletes have returned an Adverse Analytical Finding, out of the 315 athletes participating at the 2017 IWF World Championships Anaheim, USA.

The IWF conducted 212 tests including 141 urine and 43 blood, representing 67% of the total number of athletes.

These figures show a very significant improvement compared to the 2015 IWF World Championships Houston, USA where the IWF conducted 236 tests including 172 urine and 64 blood (40% of the total number of athletes).

The test distribution plan of the Event was carefully established by the IWF Anti-Doping Commission, which appointed USADA as the Sample Collection Authority.

All analyses were conducted by the independent WADA-accredited Laboratories of Montreal and Los Angeles  using the most sophisticated, internationally-recognised detection methods available.

These 4 (four) Adverse Analytical Findings are still 4 (four) too many. They do demonstrate, however, that the IWF’s comprehensive approach to eliminating doping is working well. The evident progress since Houston in 2015 will serve as further motivation to the IWF to continue implementing the toughest anti-doping programme of any international sports federation. The IWF is committed to protecting clean athletes and doing everything it can to address the incidence of doping in sport.

IWF reports that the sample of Mr. Dimitris MINASIDIS (CYP) has returned an Adverse Analytical Finding for GW501516 (S4 Hormone and Metabolic Modulators/ Peroxisome Proliferator Activated Receptor δ (PPARδ) agonists).
As a consequence, the Athlete is provisionally suspended in view of a potential anti-doping rule violation.
In any case where it is determined that the athlete did not commit an anti-doping rule violation, the relevant decision will also be published.
IWF will not make any further comments on the case until it is closed.

IWF reports that the sample of Mr. Aurimas DIDZBALIS (LTU) has returned an Adverse Analytical Finding for Selective Androgen Receptor Modulator S-22 (S1.2 Other Anabolic Agents).
As a consequence, the Athlete is provisionally suspended in view of a potential anti-doping rule violation.
In any case where it is determined that the athlete did not commit an anti-doping rule violation, the relevant decision will also be published.
IWF will not make any further comments on the case until it is closed.

IWF reports that the sample of Mr. Dumitru CAPTARI (ROU) has returned an Adverse Analytical Finding for Ephedrine (S5 Diuretics and Masking Agents).
As a consequence, the Athlete is provisionally suspended in view of a potential anti-doping rule violation.
In any case where it is determined that the athlete did not commit an anti-doping rule violation, the relevant decision will also be published.
IWF will not make any further comments on the case until it is closed.

IWF reports that the sample of Ms. Romela BEGAJ (ALB) has returned an Adverse Analytical Finding for Stanozolol (S1.1 Anabolic Agents).
As a consequence, the Athlete is provisionally suspended in view of a potential anti-doping rule violation.
In any case where it is determined that the athlete did not commit an anti-doping rule violation, the relevant decision will also be published.
IWF will not make any further comments on the case until it is closed.